Adagio Medical Advances vCLAS Ultra in Ventricular Tachycardia
LAGUNA HILLS, Calif. — September 16, 2026 Adagio Medical Holdings, Inc. announced the first patient enrollment in its FDA-approved...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
LAGUNA HILLS, Calif. — September 16, 2026 Adagio Medical Holdings, Inc. announced the first patient enrollment in its FDA-approved...
